DICE regimen: Difference between revisions
Created page with "__NOTOC__ [[{{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of dexamethasone, isofosfamide, cisplatin, and etop..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} | |||
==Overview== | ==Overview== | ||
Line 7: | Line 7: | ||
==Regimen== | ==Regimen== | ||
{{chemo|D|dexamethasone}} | {{chemo|D|dexamethasone}} | ||
{{chemo|I|isofosfamide}} | {{chemo|I|isofosfamide}} | ||
{{chemo|C|Cisplatin}} | {{chemo|C|Cisplatin}} | ||
{{chemo|E|etoposide}} | |||
==Indications== | ==Indications== | ||
*[[Non | |||
*[[Non hodgkin's lymphoma]]<ref name="pmid17166385">{{cite journal| author=Bo LJ, Liang AB, Liu B, Chen YH, Wang F, Jin XP| title=[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma]. | journal=Ai Zheng | year= 2006 | volume= 25 | issue= 12 | pages= 1553-6 | pmid=17166385 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17166385 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] |
Revision as of 20:08, 12 March 2015
WikiDoc Resources for DICE regimen |
Articles |
---|
Most recent articles on DICE regimen Most cited articles on DICE regimen |
Media |
Powerpoint slides on DICE regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on DICE regimen at Clinical Trials.gov Clinical Trials on DICE regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on DICE regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on DICE regimen Discussion groups on DICE regimen Patient Handouts on DICE regimen Directions to Hospitals Treating DICE regimen Risk calculators and risk factors for DICE regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for DICE regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2] Synonyms and keywords:
Overview
DICE regimen refers to a regimen consisting of dexamethasone, isofosfamide, cisplatin, and etoposide regimen used to treat on recurrent and refractory Non Hodgkins lymphoma.[1]
Regimen
Ddexamethasone
Iisofosfamide
CCisplatin
Eetoposide
Indications
References
- ↑ 1.0 1.1 Bo LJ, Liang AB, Liu B, Chen YH, Wang F, Jin XP (2006). "[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma]". Ai Zheng. 25 (12): 1553–6. PMID 17166385.